UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

(Mark One)

 

[X]

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2016

 

[  ]

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to ________

 

Commission File Number: 000-52635

 

ACCELERIZE INC.

(Exact name of registrant as specified in its charter)

 

Delaware  

20-3858769  

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

 

20411 SW BIRCH STREET, SUITE 250

NEWPORT BEACH

CALIFORNIA 92660

 (Address of principal executive offices)

 

(949) 548 2253

 (Registrant’s Telephone Number, including Area Code)

   

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes [X]  No [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes [X]  No [  ]

 

Indicate by check mark whether the registrant is large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐

Accelerated filer [X]

Non-accelerated filer ☐

(Do not check if smaller reporting company)

Smaller reporting company ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐   No [X]

 

The number of shares outstanding of the registrant’s Common Stock, $0.001 par value per share, as of August 5, 2016, was 65,119,540.

 

When used in this quarterly report, the terms “Accelerize,” “the Company,” “we,” “our,” and “us” refer to Accelerize Inc., a Delaware corporation.  

 

 
 

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION

 

This quarterly report on Form 10-Q contains certain forward-looking statements. Forward-looking statements may include our statements regarding our goals, beliefs, strategies, objectives, plans, including product and service developments, future financial conditions, results or projections or current expectations. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. For example, when we discuss our expectations that our revenues will increase in 2016, our expansion plans, our new products, our intentions to grow revenues by investing in sales and marketing efforts, our spending on research and development, training, and support personnel, we are using forward-looking statements. These statements are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause actual results to be materially different from those contemplated by the forward-looking statements. These factors include, but are not limited to, our ability to implement our strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors. Most of these factors are difficult to predict accurately and are generally beyond our control. You should consider the areas of risk described in connection with any forward-looking statements that may be made herein. The business and operations of Accelerize Inc. are subject to substantial risks, which increase the uncertainty inherent in the forward-looking statements contained in this report. Except as required by law, we undertake no obligation to release publicly the result of any revision to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Further information on potential factors that could affect our business is described under “Item 1A. Risk Factors” in our annual report on Form 10-K as filed with the Securities and Exchange Commission, or the SEC, on March 17, 2016. Readers are also urged to carefully review and consider the various disclosures we have made in this report and in our annual report on Form 10-K.   

 

 
 

 

 

ACCELERIZE INC.

 

INDEX

 

          

Page  

  

 

PART I - FINANCIAL INFORMATION:

1

  

 

Item 1.

Financial Statements (Unaudited)

1

  

  

 

Item 2.

Management’s Discussion and Analysis of Financial Position And Results of Operations

15

  

  

  

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

22

  

  

 

Item 4.

Controls and Procedures

22

  

  

 

PART II - OTHER INFORMATION:

23

 

 

 

Item 1.

Legal Proceedings

23

  

  

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

23

     

Item 6.

Exhibits

24

  

  

 

SIGNATURES

25

 

 
 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

ACCELERIZE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

   

June 30,

2016

   

December 31,

2015

 
   

(Unaudited)

         

ASSETS

               

Current Assets:

               

Cash

  $ 879,666     $ 908,095  
Restricted Cash     500,000       -  

Accounts receivable, net of allowance for bad debt of $390,203 and $395,147, respectively

    1,991,572       1,833,007  

Prepaid expenses and other current assets

    485,442       239,921  

Total current assets

    3,856,680       2,981,023  
                 

Property and equipment, net of accumulated depreciation of $2,113,295 and $1,854,351, respectively

    2,446,591       1,956,864  

Other assets

    110,285       124,882  

Total assets

  $ 6,413,556     $ 5,062,769  
                 

LIABILITIES AND STOCKHOLDERS' DEFICIT

               
                 

Current Liabilities:

               

Accounts payable and accrued expenses

  $ 1,871,289     $ 2,236,750  

Deferred revenues

    2,936       10,436  

Line of credit, net of deferred financing cost of $0 and $36,559, respectively

    -       4,598,441  

Other short term loan, net of deferred financing cost of $11,840 and $0, respectively

    588,160       -  

Total current liabilities

    2,462,385       6,845,627  

Line of credit, net of deferred financing cost of $514,969 and $0, respectively

    5,485,031       -  

Total liabilities

    7,947,416       6,845,627  
                 

Stockholders' Deficit

               

Common stock; $0.001 par value; 100,000,000 shares authorized; 65,059,540 and 65,069,327 shares issued and outstanding at June 30, 2016 and December 31, 2015, respectively

    65,058       65,068  

Additional paid-in capital

    24,635,377       23,440,366  

Accumulated deficit

    (26,183,118

)

    (25,266,612

)

Accumulated other comprehensive loss

    (51,177

)

    (21,680

)

                 

Total stockholders’ deficit

    (1,533,860

)

    (1,782,858

)

                 

Total liabilities and stockholders’ deficit

  $ 6,413,556     $ 5,062,769  

 

 

  See Notes to Unaudited Condensed Consolidated Financial Statements.  

 

 
1

 

 

 ACCELERIZE INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

   

Three-month periods ended

   

Six-month periods ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 
                                 

Revenues:

  $ 6,003,287     $ 5,465,824     $ 11,867,305     $ 10,665,486  

Cost of revenue

    2,030,687       1,591,345       3,962,810       2,909,111  

Gross profit

    3,972,600       3,874,479       7,904,495       7,756,375  
                                 

Operating expenses:

                               

Research and development

    973,980       1,326,410       2,004,436       2,201,792  

Sales and marketing

    874,422       1,915,053       1,867,300       4,048,977  

General and administrative

    2,247,255       2,351,430       4,535,967       4,805,876  

Total operating expenses

    4,095,657       5,592,893       8,407,703       11,056,645  
                                 

Operating loss

    (123,057

)

    (1,718,414

)

    (503,208

)

    (3,300,270

)

                                 

Other income (expense):

                               

Interest income

    11,475       21,387       20,934       54,365  

Interest expense

    (221,683

)

    (62,893

)

    (434,232

)

    (108,237

)

Total other (expenses)

    (210,208

)

    (41,506 )     (413,298

)

    (53,872

)

                                 

Net loss

  $ (333,265

)

  $ (1,759,920

)

  $ (916,506

)

  $ (3,354,142

)

                                 

Net loss per share:

                               

Basic

  $ (0.01

)

  $ (0.03

)

  $ (0.01

)

  $ (0.05

)

Diluted

  $ (0.01

)

  $ (0.03

)

  $ (0.01

)

  $ (0.05

)

                                 
                                 

Basic weighted average common shares outstanding

    65,069,327       62,835,140       65,069,327       62,833,091  

Diluted weighted average common shares outstanding

    65,069,327       62,835,140       65,069,327       62,833,091  

 

 

  See Notes to Unaudited Condensed Consolidated Financial Statements.

 

 
2

 

 

ACCELERIZE INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS

 

 

   

Three-month periods ended

   

Six-month periods ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 
                                 

Net loss

  $ (333,265

)

  $ (1,759,920

)

  $ (916,506

)

  $ (3,354,142

)

                                 

Foreign currency translation (loss) gain

    (22,309

)

    8,571       (29,497

)

    2,028  

Total other comprehensive (loss) gain

    (22,309

)

    8,571       (29,497

)

    2,028  
                                 

Comprehensive loss

  $ (355,574

)

  $ (1,751,349

)

  $ (946,003

)

  $ (3,352,114

)

 

 

See Notes to Unaudited Condensed Consolidated Financial Statements.

 

 
3

 

 

ACCELERIZE INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

   

Six-month periods ended

June 30,

 
   

2016

   

2015

 

Cash flows from operating activities:

               

Net loss

  $ (916,506

)

  $ (3,354,142

)

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    549,641       791,926  

Amortization of debt discount and deferred financing cost

    75,798       18,583  

Provision for bad debt

    (4,943

)

    (206,749

)

Fair value of options and warrants

    803,383       1,126,615  
Non-cash expenses paid on company's behalf     204,920       -  
Gain on sale of fixed assets     (447 )     -  

Changes in operating assets and liabilities:

               

Accounts receivable

    (153,622

)

    (330,277

)

Prepaid expenses and other assets

    (245,521

)

    (196,268

)

Restricted cash     (500,000 )     -  

Accounts payable and accrued expenses

    (365,461

)

    446,136  

Deferred revenues

    (7,500

)

    (149,341

)

Other assets

    8,076       (1,576

)

Net cash used in operating activities

    (552,183

)

    (1,855,093

)

                 

Cash flows from investing activities:

               

Capitalized software for internal use

    (1,030,456

)

    (368,041

)

Capital expenditures

    (7,585

)

    (115,473

)

Proceeds from sale of assets

    5,642       -  

Net cash used in investing activities

    (1,032,399

)

    (483,514

)

                 

Cash flows from financing activities:

               

Principal repayments of line of credit

    (87,777

)

    -  

Proceeds from line of credit

    1,803,105       1,600,000  

Payment of financing costs

    (129,678

)

    -  

Net proceeds from exercise of options and warrants

    -       9,586  

Net cash provided by financing activities

    1,585,650       1,609,586  
                 

Effect of exchange rate changes on cash

    (29,497

)

    2,028  
                 

Net (decrease) increase in cash

    (28,429     (726,993

)

                 

Cash, beginning of period

    908,095       1,130,667  
                 

Cash, end of period

  $ 879,666     $ 403,674  
                 

Supplemental disclosures of cash flow information:

               

Cash paid for interest

  $ 419,802     $ 106,882  

Cash paid for income taxes

  $ -     $ -  
                 

Non-cash investing and financing activities:

               

Fair value of warrants issued in connection with line of credit

  $ 391,618     $ 37,289  
Repayment of Agility Loan, included in accounts payable   $ 25,000     $ -  
Repayment of Line of Credit   $ 4,572,223     $ -  

Capital expenditure included in accounts payable

  $ -     $ 37,561  

 

 

  See Notes to Unaudited Condensed Consolidated Financial Statements.

 

 
4

 

 

ACCELERIZE INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1: ORGANIZATION AND DESCRIPTION OF BUSINESS

 

Accelerize Inc., a Delaware corporation, incorporated on November 22, 2005, owns and operates CAKE, a Software-as-a-Service, or SaaS, platform providing online tracking and analytics solutions for advertisers and online marketers.

 

The Company provides software solutions for businesses interested in expanding their online advertising spend.

 

The condensed consolidated balance sheet presented as of December 31, 2015 has been derived from our audited consolidated financial statements. The unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America, have been omitted pursuant to those rules and regulations, but we believe that the disclosures are adequate to make the information presented not misleading. The unaudited condensed consolidated financial statements and notes included herein should be read in conjunction with the annual financial statements and notes for the year ended December 31, 2015 included in our Annual Report on Form 10-K filed with the SEC on March 17, 2016.  In the opinion of management, all adjustments, consisting of normal, recurring adjustments and disclosures necessary for a fair presentation of these interim statements have been included. The results of operations for the three and six-month periods ended June 30, 2016 are not necessarily indicative of the results for the year ending December 31, 2016.

 

Principles of Consolidation

 

The accompanying unaudited condensed consolidated financial statements include the results of operations of Cake Marketing UK Ltd., or the Subsidiary. All material intercompany accounts and transactions between the Company and the Subsidiary have been eliminated in consolidation.

 

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Use of Estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid temporary cash investments with an original maturity of three months or less when purchased, to be cash equivalents.

 

 
5

 

 

Accounts Receivable

 

The Company’s accounts receivable are due primarily from advertisers and marketers. Collateral is currently not required. The Company also maintains allowances for doubtful accounts for estimated losses resulting from the inability of the Company’s customers to make payments. The Company periodically reviews these estimated allowances, including an analysis of the customers’ payment history and creditworthiness, the age of the trade receivable balances and current economic conditions that may affect a customer’s ability to make payments as well as historical collection trends for its customers as a whole. Based on this review, the Company specifically reserves for those accounts deemed uncollectible or likely to become uncollectible. When receivables are determined to be uncollectible, principal amounts of such receivables outstanding are deducted from the allowance. 

  

   

June 30,

2016

   

December 31,

2015

 
                 

Allowance for doubtful accounts

  $ 390,203     $ 395,147  

 

 

Concentration of Credit Risks

 

The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.

 

The Company’s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. During the six-month period ended June 30, 2016, the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.

 

The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. None of the Company’s customers accounted for more than 10% of its accounts receivable at June 30, 2016 or December 31, 2015.  The Company does not require any collateral from its customers.

 

Revenue Recognition

 

The Company recognizes revenue on arrangements in accordance with ASC Topic 605, Revenue Recognition. Revenue is recognized only when the price is fixed or determinable, persuasive evidence of an arrangement exists, the service is performed, and collectability of the resulting receivable is reasonably assured.

 

The Company’s SaaS revenues are generated from implementation and training fees and a monthly license fee, supplemented by per transaction fees paid by customers for monthly platform usage. The initial term of the customer contract is generally one year with one of two general cancellation policies. Each party may cancel the contract within the initial period or after the initial period, with 30-days’ prior notice. The Company does not provide any general right of return for its delivered items. Services associated with the implementation and training fees have standalone value to the Company’s customers, as there are third-party vendors who offer similar services to the Company’s services. Accordingly, they qualify as separate units of accounting. The Company allocates a fair value to each element deliverable at the recognition date and recognizes such value when the services are provided. The Company bases the fair value of the implementation and training fees on third-party evidence and the monthly license fee on vendor-specific objective evidence. Fees charged by third-party vendors for implementation and training services do not vary significantly from the fees charged by the Company. Services associated with implementation and training fees are generally rendered within a month from the initial contract date. The value attributed to the monthly license fees as well as the fees associated with monthly transaction-based platform usage are recognized in the corresponding period.

 

 
6

 

 

Product Concentration

 

The Company generates its revenues from software licensing, usage, and related transaction fees.

 

Fair Value of Financial Instruments

 

The Company accounts for assets and liabilities measured at fair value on a recurring basis in accordance with ASC Topic 820, Fair Value Measurements and Disclosures, or ASC 820. ASC 820 establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value, and expands disclosure about such fair value measurements.  

  

ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, ASC 820 requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:  

 

Level 1:

Observable inputs such as quoted market prices in active markets for identical assets or liabilities.

 

 

Level 2:

Observable market-based inputs or unobservable inputs that are corroborated by market data.

 

 

Level 3:

Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

 

Additional Disclosures Regarding Fair Value Measurements

 

The carrying value of cash and cash equivalents, accounts receivable, accounts payable, accrued expenses, lines of credit and loans, approximate their fair value due to the short term maturity of these items.

 

   

  Advertising

 

The Company expenses advertising costs as incurred.

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 
                                 

Advertising expense

  $ 39,351     $ 83,586     $ 76,677     $ 235,083  

 

Income Taxes

 

Income taxes are accounted for in accordance with the provisions of ASC Topic 740, Accounting for Income Taxes. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amounts expected to be realized, but no less than quarterly.

  

 
7

 

 

Foreign Currency Translation

 

The Company’s reporting currency is U.S. Dollars. The functional currency of the Company’s Subsidiary in the United Kingdom is British Pounds. The translation from British Pounds to U.S. Dollars is performed for balance sheet accounts using exchange rates in effect at the balance sheet date and for revenue and expense accounts using the average exchange rate in effect during the period. The resulting translation adjustments are recorded as a component of Accumulated Other Comprehensive Income (Loss). Foreign currency translation gains and losses arising from exchange rate fluctuation on transactions denominated in a currency other than the functional currency are included in the unaudited condensed consolidated statements of operations. 

 

Software Development Costs

  

Costs incurred in the research and development of software products and significant upgrades and enhancements thereto during the preliminary project stage and the post-implementation operation stage are expensed as incurred. Costs incurred for maintenance and relatively minor upgrades and enhancements are expensed as incurred. Costs associated with the application development stage of new software products and significant upgrades and enhancements thereto are capitalized when 1) management implicitly or explicitly authorizes and commits to funding a software project and 2) it is probable that the project will be completed and the software will be used to perform the function intended. The Company capitalized internal-use software development costs of $1,030,456 during the six-months ended June 30, 2016. The Company amortizes such costs once the new software products and significant upgrades and enhancements are completed. The unamortized internal-use software development costs amounted to approximately $2,203,000 and $1,548,000 at June 30, 2016 and December 31, 2015, respectively. The Company’s amortization expenses associated with capitalized software development costs amounted to $186,219 and $375,579 during the three and six-month periods ended June 30, 2016, respectively, and $175,278 and $339,132 during the three and six-month periods ended June 30, 2015, respectively. Amortization of internal-use software is reflected in cost of revenues.

 

Share-Based Payment

 

The Company accounts for stock-based compensation in accordance with ASC Topic 718, Compensation-Stock Compensation, or ASC 718. Under the fair value recognition provisions of this topic, stock-based compensation cost is measured at the grant date based on the fair value of the award and is recognized as an expense on a straight-line basis over the requisite service period, which is the vesting period.

 

The Company has elected to use the BSM option-pricing model to estimate the fair value of its options, which incorporates various subjective assumptions including volatility, risk-free interest rate, expected life, and dividend yield to calculate the fair value of stock option awards. Compensation expense recognized in the statements of operations is based on awards ultimately expected to vest and reflects estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

 

Segment Reporting

 

The Company generated revenues from one source, its SaaS business, during the three and six-month periods ended June 30, 2016 and 2015. The Company's chief operating decision maker evaluates the performance of the Company based upon revenues and expenses by functional areas as disclosed in the Company's statements of operations.

 

Recent Accounting Pronouncements

 

The Company applied ASU 2015-03: Interest – Imputation of Interest, which simplifies the presentation of debt issuance costs, and netted debt issue costs previously reported as assets with the related liability for presentation purposes. Other accounting pronouncements have been issued but deemed by management to be outside the scope of relevance to the Company.  

 

Reclassification

 

The balance sheet, and related footnotes, for the year ended December 31, 2015 has been reclassified to reflect the adoption of ASU 2015-03 which changes the presentation of debt issuance costs in financial statements and requires an entity to present such costs in the balance sheet as a direct deduction from the related debt liability rather than as an asset.

 

Basic and Diluted Earnings Per Share

 

Basic earnings per share are calculated by dividing income available to stockholders by the weighted-average number of common shares outstanding during each period. Diluted earnings per share are computed using the weighted average number of common and dilutive common share equivalents outstanding during the period. Dilutive common share equivalents consist of shares issuable upon the exercise of stock options and warrants (calculated using the modified-treasury stock method).

 

 
8

 

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 

Numerator:

                               

Net loss

  $ (333,265

)

  $ (1,759,920

)

  $ (916,506

)

  $ (3,354,142

)

                                 

Denominator:

                               

Denominator for basic earnings per share--weighted average shares

    65,069,327       62,835,140       65,069,327       62,833,091  

Effect of dilutive securities- when applicable:

                               

Stock options

    -       -       -       -  

Warrants

    -       -       -       -  

Denominator for diluted earnings per share--adjusted weighted-average shares and assumed conversions

    65,069,327       62,835,140       65,069,327       62,833,091  
                                 

Loss per share:

                               

Basic

  $ (0.01

)

  $ (0.03

)

  $ (0.01

)

  $ (0.05

)

Diluted

  $ (0.01

)

  $ (0.03

)

  $ (0.01

)

  $ (0.05

)

                                 
                                 

Weighted-average anti-dilutive common share equivalents

    18,551,891       15,159,042       18,710,764       17,443,244  

 

 
Property and Equipment

 

Property and equipment are recorded at cost and are depreciated on a straight-line basis over their estimated useful lives of three years. Maintenance and repairs are charged to expense as incurred. Significant renewals and betterments are capitalized

 

Property and equipment consist of the following at:

 

   

June 30,

2016

   

December 31,

2015

 

Internal use software costs

  $ 3,756,665     $ 2,726,209  

Computer equipment and software

    381,653       563,892  

Office furniture and equipment

    129,422       222,061  

Leasehold improvements

    292,146       299,053  
      4,559,886       3,811,215  

Accumulated depreciation

    (2,113,295

)

    (1,854,351

)

    $ 2,446,591     $ 1,956,864  

 

  

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 
                                 

Depreciation expense

  $ 96,749     $ 83,996     $ 174,062     $ 156,498  

Amortization expense on internal software

  $ 186,219     $ 175,278     $ 375,579     $ 339,132  

 

During the six-month period ended June 30, 2016, the Company sold approximately $12,000 in computer equipment with a net book value of approximately $5,000 for proceeds of approximately $6,000.

 

During the six-month period ended June 30, 2016, the Company wrote off approximately $280,000 in fixed assets with a net book value of approximately $31,000, which was recorded under the depreciation expense account.

 

NOTE 3: PREPAID EXPENSES  

 

At June 30, 2016 and December 31, 2015, the Company’s prepaid expenses consisted primarily of prepaid insurance and rent.

 

 
9

 

 

NOTE 4: DEFERRED REVENUES

 

The Company’s deferred revenues consist of prepayments made by certain of the Company’s customers and undelivered implementation and training fees.  The Company decreases the deferred revenues by the amount of the services it renders to such clients when provided.

 

   

June 30,

2016

   

December 31,

2015

 
                 

Deferred revenues

  $ 2,936

 

  $ 10,436  

 

 

NOTE 5: LINE OF CREDIT AND LOANS

 

Line of Credit

 

   

June 30,

2016

   

December 31,

2015

 

Line of credit

    4,635,000       4,635,000  

Repayment of Line of credit

    (4,635,000

)

    -  

Less: Deferred financing cost

    -       (36,559

)

    $ -     $ 4,598,441  

 

On September 30, 2014, the Company entered into an amendment of its line of credit, or the Line of Credit, with Pacific Western Bank, as successor in interest by merger to Square 1 Bank, or the Lender, to borrow up to a maximum of $6,000,000 at the Company’s discretion, an increase from up to $3,000,000 that the Company was permitted to borrow under the original Line of Credit entered into on March 17, 2014. Amounts borrowed accrued interest at the prime rate in effect from time to time plus 1.25%, not to be less than 5.5% per annum, provided that in no event shall the accrued interest payable with respect to any month be less than $10,000. Accrued interest on amounts borrowed was payable monthly. All other amounts borrowed were to be payable in full on the maturity date of March 17, 2016; however, this date was extended by the Lender until May 31, 2016. This maturity extension was granted concurrently with a waiver issued by the Lender pursuant to an amendment to the Line of Credit on March 11, 2016, which amendment waived any default due to breach of the Line of Credit minimum liquidity covenant during the specified time period, adjusts the Minimum Adjusted EBITDA covenant, and reduces the credit limit to $5,135,000. A condition precedent to the waiver was the funding of a $625,000 subordinated loan, or the Agility Loan, from Agility Capital II, LLC, or Agility Capital, which funded on March 11, 2016. The Line of Credit may be earlier terminated without a prepayment fee. The Company also made a repayment of $62,777 in March 2016.

 

In connection with the original Line of Credit, the Company issued to the Lender a warrant to purchase up to 46,875 shares of the Company’s Common Stock at an exercise price of $1.60 per share. The warrant expires on March 17, 2017. The fair value of the warrant amounted to $32,067. On March 27, 2015, in connection with an obligation under the Line of Credit when borrowings thereunder exceed $3,000,000, the Company issued to the Lender a warrant to purchase 58,824 shares of the Company’s Common Stock at an exercise price of $1.53 per share. This warrant expires on March 27, 2018. The fair value of the warrant amounted to $37,289.

 

As further described below, on May 5, 2016, the Company entered into a loan and security agreement, or the SaaS Capital Loan, with SaaS Capital Funding II, LLC to borrow up to a maximum of $8,000,000. On May 5, 2016, the Company drew down $5,000,000 as the initial advance from the SaaS Capital Loan and used a portion of the proceeds, $4,572,223, to repay the outstanding Line of Credit balance.

 

As of June 30, 2016, the Company had no outstanding balance under the Line of Credit.

 

 
10

 

 

The Company paid approximately $50,000 to the Lender in financing costs through December 31, 2015, and approximately $69,000 through June 30, 2016. The deferred financing costs associated with the Line of Credit were fully expensed at June 30, 2016.

 

Agility Loan  

 

   

June 30,

2016

   

December 31,

2015

 

Agility Loan

    625,000       -  

Principal Payment of Agility Loan

    (25,000

)

    -  

Less: Deferred financing cost

    (11,840

)

    -  
    $ 588,160     $ -  

 

On March 11, 2016, the Company entered into a subordinated loan with Agility Capital which provides for total availability of $625,000 and matures on March 31, 2017. The Agility Loan has a fixed interest rate of 12% per year and requires $25,000 monthly amortization payments beginning on June 1, 2016. The Agility Loan also requires fees of approximately $130,000 over the life of the loan, and is subject to a total aggregate minimum interest of $50,000 in the event of a prepayment. The Agility Loan contains covenants to achieve specified Adjusted EBITDA levels, as defined, limiting capital expenditures, restricting the Company’s ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. As of June 30, 2016, the Company was in compliance with these covenants. The Agility Loan requires a security interest in all of the Company’s personal property and intellectual property, second in priority to the Lender and to SaaS Capital Funding II, LLC.

 

In connection with the Agility Loan, Agility Capital is entitled to purchase, under certain circumstances, fully paid and nonassessable shares of the Company’s class of securities, or Shares, at the initial exercise price per Share which is the closing price on the day prior to the issuance date, or the Warrant Price. The initial number of Shares issuable upon exercise of this Warrant is zero (0). On June 30, 2016, if any amounts under the Agility Loan remain outstanding, then the number of Shares issuable upon exercise of this Warrant shall equal $31,250 divided by the Warrant Price. In addition to the foregoing, upon the occurrence of an Event of Default, as defined in the loan agreement, pursuant to Section 5(a) or Section 5(b) of the Agility Loan, the number of Shares that may be acquired thereunder shall increase by an additional number of Shares equal to 5% of the number of Shares issuable thereunder upon the date of such Event of Default, and further increased on the 15th day following such Event of Default and on each 15th day thereafter (each, a "Measurement Date”) by a number of Shares equal to 5% of the number of Shares issuable upon such Measurement Date, until the Event of Default is cured to Agility Capital’s satisfaction or waived in writing by Agility Capital. As of June 30, 2016, as a result of outstanding amounts under the Agility Loan, the Company issued to Agility Capital a warrant to purchase up to 69,444 shares of the Company’s Common Stock at an exercise price of $0.45 per share. This warrant expires on March 11, 2021. The fair value of the warrant amounted to $15,787 and was capitalized as deferred financing costs at June 30, 2016.

 

The Company owed $600,000 under the Agility Loan at June 30, 2016.

 

SaaS Capital Loan  

 

   

June 30,

2016

   

December 31,

2015

 

SaaS Capital Loan

    6,000,000       -  

Less: Deferred financing cost

    (514,969

)

    -  
    $ 5,485,031     $ -  

 

On May 5, 2016, the Company entered into the SaaS Capital Loan, with SaaS Capital Funding II, LLC to borrow up to a maximum of $8,000,000. Initial amounts borrowed will accrue interest at the rate of 10.25% per annum with future amounts borrowed bearing interest at the greater of 10.25% or 9.21% plus the three-year treasury rate at the time of advance. Accrued interest on amounts borrowed is payable monthly for the first six months and thereafter 36 equal monthly payments of principal and interest is payable. Prepayments will be subject to a 10%, 6% or 3% of principal premium if prepaid prior to 12 months, between 12 and 24 months, or between 24 months and maturity, respectively. Advances may be requested until May 5, 2018. The initial minimum advance amount of $5,000,000, on May 5, 2016, was used to repay the outstanding Line of Credit balance of $4,572,223. A facility fee of $80,000 was paid by the Company in connection with the initial advance and an additional $80,000 is payable on May 5, 2017.

 

 
11

 

 

The SaaS Capital Loan contains customary covenants including, but not limited to, covenants to achieve specified Adjusted EBITDA levels and revenue renewal levels, limiting capital expenditures and restricting the Company's ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. As of June 30, 2016, the Company was in compliance with such covenants. The occurrence of a material adverse change will be an event of default under the SaaS Capital Loan, in addition to other customary events of default. The Company granted SaaS Capital Funding II, LLC a security interest in all of the Company's personal property and intellectual property through the SaaS Capital Loan and the Patent, Trademark and Copyright Security Agreement between the Company and SaaS Capital Funding II, LLC.

 

As of June 30, 2016, in connection with the SaaS Capital Loan, the Company issued to SaaS Capital Partners II, LP, an affiliate of SaaS Capital Funding II, LLC, a warrant to purchase up to 1,333,333 shares of the Company's common stock at an exercise price of $0.45 per share subject to certain adjustments for dividends, splits or reclassifications. The Warrant is exercisable until the earlier of May 5, 2026, or the date that is 5 years from the date the Company’s equity securities are first listed for trading on NASDAQ. The Company paid approximately $169,000 in financing costs through June 30, 2016. The fair value of the warrant amounted to $375,831.

 

The Company owed $6,000,000 under the SaaS Capital Loan at June 30, 2016.

 

The Company recognized amortization and interest expenses in connection with the line of credit and loans for the three and six-month periods ended June 30, 2016 and 2015 as follows.

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 
                                 

Amortization expense associated with line of credit and loans

  $ 62,432     $ 11,033     $ 75,798     $ 18,583  

Interest expense associated with line of credit and loans

  $ 108,065     $ 50,845     $ 171,092     $ 88,300  

 

 

NOTE 6: STOCKHOLDERS’ EQUITY

 

Common Stock

 

During the six-month period ended June 30, 2015, the Company generated proceeds of $9,586 from the exercise of 11,457 options and issued 5,233 shares of its Common Stock pursuant to the cashless exercise of 11,458 options.   

There were no exercises of options during the six-month period ended June 30, 2016.

 

As of June 30, 2016 and December 31, 2015, there were 65,059,540 and 65,069,327 shares of Common Stock issued and outstanding, respectively. 

 

Warrants

 

During the six-month period ended June 30, 2015, the Company issued 58,824 warrants to the Lender. The warrants are exercisable at a price of $1.53 per share and expire on March 27, 2018. The fair value of these warrants which amounted to $37,289, has been recognized as deferred financing fees and is amortized using the effective interest method over the terms of the associated Line of Credit.

 

During the six-month period ended June 30, 2016, the Company issued 69,444 and 1,333,333 warrants to Agility Capital and SaaS Capital Partners II, LP, respectively, exercisable at a price of $0.45 per share and which expire on March 11, 2021 and May 5, 2026 respectively.  The fair value of these warrants, which amounted to $15,787 and $375,831, respectively, were recognized as deferred financing fees and amortized using the effective interest method over the terms of the associated loan.

 

The fair value of the warrants granted during the six-month period ended June 30, 2016 is based on the BSM model using the following assumptions:

 

Effective Exercise price

  $0.45 - 1.53  

Effective Market price

  $0.41 - 1.53  

Volatility

  62 - 70

%

Risk-free interest

  0.7 - 0.9

%

Term (years)

  3 - 10  

Expected dividend rate

      0

%

 

During the six-month period ended June 30, 2016, 2,466,760 warrants were forfeited, of which 1,650,000 warrants were forfeited and replaced with 2,000,000 new warrants issued in conjunction with the forfeiture of 650,000 options issued in December 2014. 

 

As of June 30, 2016 and December 31, 2015, there were 7,603,716 and 6,667,699 warrants issued and outstanding, respectively, with a weighted average price at $0.88 and $1.25, respectively.

 

During the three and six-month periods ended June 30, 2016, the Company recorded expenses of $270,508 and $554,601, respectively, related to warrants granted to employees. During the three and six-month periods ended June 30, 2015, the Company recorded expenses of $284,093 and $568,186, respectively, related to warrants granted to employees in prior years.

 

 

Stock Option Plan

 

The Company has a Stock Option Plan, or the Plan, under which the total number of shares of capital stock of the Company that may be subject to options under the Plan is currently 22,500,000 shares of Common Stock from either authorized but unissued shares or treasury shares. The individuals who are eligible to receive option grants under the Plan are employees, directors and other individuals who render services to the management, operation or development of the Company or its subsidiaries and who have contributed or may be expected to contribute to the success of the Company or a subsidiary. Every option granted under the Plan shall be evidenced by a written stock option agreement in such form as the Board shall approve from time to time, specifying the number of shares of Common Stock that may be purchased pursuant to the option, the time or times at which the option shall become exercisable in whole or in part, whether the option is intended to be an incentive stock option or a non-incentive stock option, and such other terms and conditions as the Board shall approve.

 

 
12

 

 

The share-based payment is based on the fair value of the outstanding options amortized over the requisite period of service for option holders, which is generally the vesting period of the options. The fair value of the options granted during the six-month periods ended June 30, 2016 and 2015 is based on the BSM model using the following assumptions:

 

 

 

June 30, 2016

 

 

June 30, 2015

 

Effective exercise price

 

$

0.45

-

0.50

 

 

$

1.40

-

1.43

 

Effective market price

 

$

0.45

-

0.50

 

 

$

1.40

-

1.43

 

Volatility

 

 

 

70%

 

 

 

 

61

-

62%

 

Risk-free interest

 

 

0.7

-

0.9%

 

 

 

0.9

-

1.0%

 

Terms (years)

 

 

3

-

4

 

 

 

2

-

4

 

Expected dividend rate

 

 

 

0%

 

 

 

 

 

0%

 

 

 

The Company generally recognizes its share-based payment over the vesting terms of the underlying options.

 

   

Six-month periods ended

 
   

June 30,

2016

   

June 30,

2015

 

Weighted-average grant date fair value

  $ 0.50     $ 0.52  

Fair value of options, recognized as selling, general, and administrative expenses

  $ 248,783     $ 558,430  

Number of options granted

    2,020,000       390,000  

 

The total compensation cost related to non-vested awards not yet recognized amounted to $681,633 at June 30, 2016 and the Company expects that it will be recognized over the following weighted-average period of 48 months.

 

If any options granted under the Plan expire or terminate without having been exercised or cease to be exercisable, such options will be available again under the Plan. All employees of the Company and its subsidiaries are eligible to receive incentive stock options and non-qualified stock options. Non-employee directors and outside consultants who provided bona-fide services not in connection with the offer or sale of securities in a capital raising transaction are eligible to receive non-qualified stock options. Incentive stock options may not be granted below their fair market value at the time of grant or, if to an individual who beneficially owns more than 10% of the total combined voting power of all stock classes of the Company or a subsidiary, the option price may not be less than 110% of the fair value of the Common Stock at the time of grant. The expiration date of an incentive stock option may not be longer than ten years from the date of grant. Option holders, or their representatives, may exercise their vested options up to three months after their employment termination or one year after their death or permanent and total disability. The Plan provides for adjustments upon changes in capitalization.

 

The Company’s policy is to issue shares pursuant to the exercise of stock options from its available authorized but unissued shares of Common Stock. It does not issue shares pursuant to the exercise of stock options from its treasury shares.

 

NOTE 7: COMPREHENSIVE LOSS

 

Comprehensive (loss) income includes changes in equity related to foreign currency translation adjustments. The following table sets forth the reconciliation from net (loss) income to comprehensive (loss) income for the three and six-month periods ended June 30, 2016 and 2015:

 

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 

Net loss

  $ (333,265

)

  $ (1,759,920

)

  $ (916,506

)

  $ (3,354,142

)

Other comprehensive income (loss):

                               

Foreign currency translation adjustment

    (22,309 )     8,571       (29,497

)

    2,028  

Comprehensive loss

  $ (335,574

)

  $ (1,751,349

)

  $ (946,003

)

  $ (3,352,114

)

  

 
13

 

 

The following table sets forth the balance in accumulated other comprehensive loss as of June 30, 2016 and December 31, 2015, respectively: 

 

   

June 30,

   

December 31,

 
   

2016

   

2015

 

Accumulated other comprehensive income

  $ (51,177

)

  $ (21,680

)

 

NOTE 8: SEGMENTS

 

The Company operates in one business segment. Percentages of sales by geographic region for the three and six-month periods ended June 30, 2016 and 2015 were approximately as follows:

 

   

Three months ended

   

Six months ended

 
   

June 30,

   

June 30,

 
   

2016

   

2015

   

2016

   

2015

 

United States

    67%       72%       68%       73%  

Europe

    19%       19%       19%       19%  

Other

    14%       9%       13%       8%  

   

NOTE 9: COMMITMENTS AND CONTINGENCIES

 

During January 2014, the Company entered into a 4-year lease for certain office space in Newport Beach, effective February 1, 2014. Under the terms of the lease, the Company initially paid monthly base rent of approximately $22,000 increasing incrementally to approximately $25,000.

 

During July 2014, the Company entered into a five year lease for certain office space in a business center in London, England, which commenced on July 30, 2014. The base rent is GBP 89,667 (approximately $129,000) per year and the estimated service charges for the lease are GBP 45,658 (approximately $66,000) per year. The Company paid approximately GBP 60,000 (approximately $86,000) for furniture, cabling and build out of the office space 

 

Legal Proceedings

 

From time to time, the Company may become involved in legal proceedings arising in the ordinary course of business. The Company is not presently a party to any legal proceedings, including the following, that it currently believes, if determined adversely to the Company, would individually or taken together have a material adverse effect on the Company’s business, operating results, financial condition or cash flows.

 

 

McCollum Litigation

 

The Company is currently involved in a litigation with Jeff McCollum, the former President of its CAKE division, in the Superior Court of the State of California, commenced by the Company on February 22, 2015, whereby it asserted claims against Mr. McCollum for fraud, breach of contract, and breach of fiduciary duty, among others, following its termination of Mr. McCollum’s employment on September 8, 2014 for cause as a result of, among other things, Mr. McCollum having abandoned his position and professional responsibilities. Mr. McCollum filed a cross complaint alleging breach of contract by the Company with respect to Mr. McCollum’s employment agreement and commenced a separate action on February 23, 2015 in the Superior Court of the State of California asserting claims against the Company for violation of California Commercial Code §8401 and breach of fiduciary duty arising from Mr. McCollum’s request to have the restrictive legend removed from his share certificate representing 1.89 million shares of the Company’s Common Stock owned by him, and seeking declaratory relief as to whether he is entitled to have the restrictive legend removed from his share certificate. On April 27, 2016, the court granted Mr. McCollum summary adjudication as to his declaratory relief cause of action to have the restrictive legend removed from his share certificate.

 

NOTE 10: SUBSEQUENT EVENTS    

 

On July 1, 2016, the Company granted to each of its non-employee directors, as partial annual compensation for services as a director, a restricted stock award consisting of 120,000 shares of the Company’s Common Stock at $0.50 per share having a value of $60,000.  These shares vest in four equal quarterly increments commencing on July 1, 2016.

 

 
14

 

 

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion of our financial condition and results of operations should be read in conjunction with the financial statements and related notes included elsewhere in this report and our Annual Report on Form 10-K for the year ended December 31, 2015. Certain statements in this discussion and elsewhere in this report constitute forward-looking statements. See “Cautionary Statement Regarding Forward Looking Information’’ elsewhere in this report. Because this discussion involves risk and uncertainties, our actual results may differ materially from those anticipated in these forward-looking statements

 

Overview

 

We own and operate CAKE and getcake.com, a marketing technology that provides a comprehensive suite of innovative marketing intelligence tools. Our powerful SaaS enterprise solution has been an industry standard for advertisers, networks, publishers, and agencies to measurably improve and optimize their digital spend. We have over 500 customers driving billions of consumer actions monthly through the CAKE enterprise platform.

 

Our revenue model is based on a monthly license fee, a usage fee (based on volume of clicks, impressions, or leads), a training and implementation fee, and in certain cases, professional services fees and royalties. Clients purchase annual or monthly subscriptions with an additional usage fee. A majority of our revenue is derived from clients in the United States but we have seen a 19% growth in our client base outside of the United States during the six-month period ended June 30, 2016 when compared to the same period in 2015.

 

Our training, support personnel, hosting and cloud-based infrastructure contribute to our cost of operating the business. We anticipate more spending in these areas while we continue to grow and could foresee some savings in infrastructure cost due to economies of scale. However, we want to continue to invest in these areas to support our growth.

 

We experienced 11% year over year growth in revenue during the six-month period ended June 30, 2016 when compared to the same period in 2015. We experienced a 30% year over year growth in monthly license fee revenue during the six-month period ended June 30, 2016 when compared to the same period in 2015. The organic growth has been a result of providing the marketing technology industry a comprehensive suite of marketing intelligence tools through innovation and what we believe to be a superior product and customer experience.

 

We allocated a portion of our marketing budget to being present at tradeshows, writing for and participating in industry publications, and providing the support documentation required by sales initiatives. Additional efforts will be made to speak at industry events and write for online publications, increasing awareness of the CAKE suite of products and the thought leadership driving product development.

 

Our principal offices are located at 20411 SW Birch Street, Suite 250, Newport Beach, CA 92660. Our telephone number there is: (949) 548-2253. Our corporate website is: www.accelerize.com, the contents of which are not part of this quarterly report.

 

Our Common Stock is quoted on the OTCQB Marketplace under the symbol "ACLZ."

 

 
15

 

 

Results of Operations

 

ACCELERIZE INC.

UNAUDITED CONDENSED CONSOLIDATED RESULTS OF OPERATIONS

 

   

Three-month periods

   

Increase/

   

Increase/

   

Six-month periods

   

Increase/

   

Increase/

 
   

ended June 30,

   

(Decrease)

   

(Decrease)

   

ended June 30,

   

(Decrease)

   

(Decrease)

 
   

2016

   

2015

    $    

%

   

2016

   

2015

    $    

%

 
                                                                 

Revenues:

  $ 6,003,287     $ 5,465,824       537,463       9.8 %   $ 11,867,305     $ 10,665,486       1,201,819       11.3 %

Cost of revenue

    2,030,687       1,591,345       439,342       27.6 %   $ 3,962,810     $ 2,909,111       1,053,699       36.2 %

Gross Profit

    3,972,600       3,874,479       98,121       2.5 %     7,904,495       7,756,375       148,120       1.9 %
                                                                 

Operating expenses:

                                                               

Research and development

    973,980       1,326,410       (352,430 )     -26.6 %   $ 2,004,436     $ 2,201,792       (197,356 )     -9.0 %

Sales and marketing

    874,422       1,915,053       (1,040,631 )     -54.3 %   $ 1,867,300     $ 4,048,977       (2,181,677 )     -53.9 %

General and administrative

    2,247,255       2,351,430       (104,175 )     -4.4 %   $ 4,535,967     $ 4,805,876       (269,909 )     -5.6 %

Total operating expenses

    4,095,657       5,592,893       (1,497,236 )     -26.8 %     8,407,703       11,056,645       (2,648,942 )     -24.0 %
                                                                 

Operating loss

    (123,057 )     (1,718,414 )     (1,595,357 )     -92.8 %     (503,208 )     (3,300,270 )     2,797,062       -84.8 %
                                                                 

Other income (expense):

                                                               

Other income

    11,475       21,387       (9,912 )     -46.3 %   $ 20,934     $ 54,365       (33,431 )     -61.5 %

Other expense

    (221,683 )     (62,893 )     158,790       252.5 %   $ (434,232 )   $ (108,237 )     325,995       301.2 %

Total other expenses

    (210,208 )     (41,506 )     168,702       406.5 %     (413,298 )     (53,872 )     359,426       667.2 %
                                                                 

Net loss

  $ (333,265 )   $ (1,759,920 )     (1,426,655 )     -81.1 %   $ (916,506 )   $ (3,354,142 )     (2,437,636 )     -72.7 %

 

 
16

 

 

Discussion of Results for Three-Month and Six-Month Periods Ended June 30, 2016 and 2015

 

Revenues

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

Revenues

  $ 6,003,287     $ 5,465,824       9.8

%

  $ 11,867,305     $ 10,665,486       11.3

%

 

We generate revenues from a monthly license fee, a usage fee (based on volume of clicks, impressions, or leads), a training and implementation fee, and in certain cases, professional services fees, and royalties. Our revenue breakdown for the three and six-month periods ended June 30, 2016 and 2015 were as follows.

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

License

    4,608,414       3,493,511       31.9 %     9,005,249       6,909,277       30.3 %

Usage

    891,447       968,675       -8.0 %     1,835,819       1,979,030       -7.2 %

Other

    503,396       1,003,638       -49.8 %     1,026,237       1,777,179       -42.3 %

Total

  $ 6,003,287     $ 5,465,824       9.8 %   $ 11,867,305     $ 10,665,486       11.3 %

 

The increases in our software licensing revenues during the three and six-month periods ended June 30, 2016, when compared to the prior year periods, is due to the increased number of customers using our SaaS products and services, as well as increased monthly revenues from our existing customers resulting from greater adoption and higher usage of our SaaS platform. Our monthly license fee revenue, which constitutes the contractually recurring portion of our revenue and comprises the bulk of our total revenue, or 76% for the six-month period ended June 30, 2016, increased 30% year over year during the six-month period ended June 30, 2016 when compared to the same period in 2015. Our average monthly revenue per customer increased 7% and 8% during the three and six-month periods ended June 30, 2016, respectively, when compared to the prior year periods. The increases in the number of customers using our SaaS products and services during the three and six-month periods ended June 30, 2016 is primarily due to the increased resources we have devoted to customer acquisition for our SaaS products. The higher average monthly revenues from our existing customers is primarily due to higher market acceptance and adoption among our users, resulting in a higher volume of transactions.

 

We believe that our SaaS revenues will continue to increase during the remainder of 2016 when compared to 2015.

 

Cost of Revenues

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

Cost of revenues

  $ 2,030,687     $ 1,591,345       27.6

%

  $ 3,962,810     $ 2,909,111       36.2

%

 

 

Cost of revenues consists primarily of web hosting and personnel costs associated with supporting customer on-boarding and training activities, including salaries, benefits, and related infrastructure costs. Web hosting fees are partially correlated to our revenues, depending on each specific agreement we have with our clients. The majority of our clients’ services are hosted on non-dedicated servers, on which capacity can be maximized by server, while certain customers prefer to have their services hosted on dedicated servers, on which capacity can only be maximized by customer and by server. Additionally, our resources associated with on-boarding are usually allocated at the beginning of the relationship with the new customer (usually, the first two months). Accordingly, our personnel costs associated with supporting customer on-boarding activities are not necessarily correlated with our revenues.

 

During the three and six-month periods ended June 30, 2016, when compared to the prior year periods, cost of revenues significantly increased reflecting the higher web hosting fees incurred to support our increased number of clients and platform usage, which increased during the three and six-month periods ended June 30, 2016 by approximately $440,000 and $830,000, respectively, when compared to the same periods in 2015.

 

We believe that our cost of revenues will continue to increase, at lower percentages than our anticipated increase in revenues, during the remainder of 2016, when compared to 2015.

 

 
17

 

 

Research and Development Expenses

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

Research and development

  $ 973,980     $ 1,326,410       -26.6

%

  $ 2,004,436     $ 2,201,792       -9.0

%

 

Research and development expenses consist primarily of personnel costs associated with the enhancement and maintenance of our SaaS product offerings, consisting of salaries, benefits, and related infrastructure costs, offset by capitalized software development costs.  

 

Our research and development expenses decreased during the three and six-month periods ended June 30, 2016, when compared to the prior year periods, mainly due to increased capitalization of software development costs which amounted to $555,456 and $1,030,456 for the three and six-month periods ended June 30, 2016, respectively.

 

We believe that our research and development expenses will increase gradually during the remainder of 2016 at lower levels than the prior year, as we continue to enhance the features of our SaaS platform.

  

Sales and Marketing Expenses

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

Sales and marketing

  $ 874,422     $ 1,915,053       -54.3

%

  $ 1,867,300     $ 4,048,977       -53.9

%

 

Sales and marketing expenses consist primarily of personnel costs associated with the sale and marketing of our SaaS products, including salaries, benefits, and related infrastructure, as well as the costs of related marketing programs, such as trade shows and public relations.

 

The decreases in sales and marketing expenses during the three and six-month periods ended June 30, 2016, when compared to the prior year periods, are primarily due to more efficient spending in specific, higher return, marketing programs and trade shows, as well as a reduction in personnel costs in both the marketing and sales departments.

 

We believe that our sales and marketing expenses will increase gradually during the remainder of 2016, at substantially lower levels than the prior year, as we continue to execute on proven marketing programs.

 

General and Administrative Expenses

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

General and administrative

  $ 2,247,255     $ 2,351,430       -4.4

%

  $ 4,535,967     $ 4,805,876       -5.6

%

 

General and administrative expenses primarily consist of personnel costs associated with the support of our operations consisting of salaries, benefits, and related infrastructure. Also included are non-personnel costs, such as audit fees, accounting services and legal fees, as well as professional fees, insurance and other corporate expenses such as investor relations.

 

 
18

 

 

The decreases in general and administrative expenses during the three and six-month periods ended June 30, 2016, when compared to the prior year periods, are primarily due to the reduction in personnel.

 

We believe that our general and administrative expenses will increase during the remainder of 2016 as we continue to increase the scope of our operations.

 

Other Income

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

Other income

  $ 11,475     $ 21,387       -46.3

%

  $ 20,934     $ 54,365       -61.5

%

 

Other Income during the three and six-month periods ended June 30, 2016 consisted mainly of the sale of non-inventory assets while during the three and six-month periods ended June 30, 2015, other income consisted of the sale of non-inventory assets as well as rent from a sublease of our Santa Monica office space.  

 

Other Expenses

 

   

Three Months Ended

   

%

   

Six Months Ended

   

%

 
   

June 30,

   

Change

   

June 30,

   

Change

 
   

2016

   

2015

           

2016

   

2015

         
                                                 

Other expenses

  $ 221,683     $ 62,893       252.5

%

  $ 434,232     $ 108,237       301.2

%

 

Other expenses consist of interest charges and amortization of deferred financing costs associated with our loans.

 

The increases in interest expenses during the three and six-month periods ended June 30, 2016, when compared to the prior year periods, are primarily due to higher levels of borrowings we have made from time to time under the Line of Credit and debt issue costs related to the Agility and SaaS Capital Loans. Our interest expense may change during the remainder of 2016 depending on our liquidity needs and we may choose to further finance our working capital needs through our operations, from borrowings, or by issuing securities.

 

Liquidity and Capital Resources

 

   

Ending balance at

   

Average balance during

 
   

June 30,

   

six months ended June 30,

 
   

2016

   

2015

   

2016

   

2015

 

Cash

  $ 879,666     $ 403,674     $ 893,881     $ 767,171  

Accounts receivable

    1,991,572       2,286,592       1,912,290       2,018,079  

Accounts payable and accrued expenses

    1,871,290       1,689,693       2,054,020       1,446,094  

S/T Line of Credit, net of deferred financing cost

    -       -       2,299,221       -  

Short term loan, net of deferred financing cost

    588,160       -       294,080       -  

Long term loan, net of deferred financing cost

    5,485,031       4,500,000       2,742,516       3,700,000  


At June 30, 2016 and 2015, 53% and 57%, respectively, of our total assets consisted of cash and cash equivalents and accounts receivable.

 

We extend unsecured credit in the normal course of business to our customers. The determination of the appropriate amount of the reserve for uncollectible accounts is based upon a review of the amount of credit extended, the length of time each receivable has been outstanding, and the specific customers from whom the receivables are due.

 

The objective of liquidity management is to ensure that we have ready access to sufficient funds to meet commitments while implementing our growth strategy. Our primary sources of liquidity historically include the sale of our securities and borrowings from our Line of Credit.

 

We do not have any material commitments for capital expenditures of tangible items.

 

 
19

 

 

Line of Credit  

 

On September 30, 2014, we entered into an amendment of our Line of Credit to borrow up to a maximum of $6,000,000 at our discretion, an increase from up to $3,000,000 that we were permitted to borrow under the original Line of Credit entered into on March 17, 2014. Amounts borrowed accrued interest at the prime rate in effect from time to time plus 1.25%, not to be less than 5.5% per annum, provided that in no event shall the accrued interest payable with respect to any month be less than $10,000. Accrued interest on amounts borrowed was payable monthly. All other amounts borrowed were to be payable in full on the maturity date of March 17, 2016; however, this date was extended by the Lender until May 31, 2016. This maturity extension was granted concurrently with a waiver issued by the Lender pursuant to an amendment to the Line of Credit on March 11, 2016, which amendment waives any default due to breach of the Line of Credit minimum liquidity covenant during the specified time period, adjusts the Minimum Adjusted EBITDA covenant, and reduces the credit limit to $5,135,000. A condition precedent to the waiver was the funding of the $625,000 subordinated loan from Agility Capital, which funded on March 11, 2016. The Line of Credit may be earlier terminated without a prepayment fee.

 

In connection with the original Line of Credit, we issued to the Lender a warrant to purchase up to 46,875 shares of our Common Stock at an exercise price of $1.60 per share. The warrant expires on March 17, 2017. The fair value of the warrant amounted to $32,067. On March 27, 2015, in connection with an obligation under the Line of Credit when borrowings thereunder exceed $3,000,000, we issued to the Lender a warrant to purchase 58,824 shares of our Common Stock at an exercise price of $1.53 per share. This warrant expires on March 27, 2018. 

 

On May 5, 2016, we repaid the outstanding Line of Credit balance with the initial advance from our SaaS Capital Loan, which became effective on May 5, 2016.  

 

Agility Loan

 

On March 11, 2016, we entered into a subordinated loan with Agility Capital which provides for total availability of $625,000 and matures on March 31, 2017. The Agility Loan has a fixed interest rate of 12% per year and requires $25,000 monthly amortization payments beginning on June 1, 2016. The Agility Loan also requires fees of approximately $130,000 over the life of the loan, and is subject to a total aggregate minimum interest of $50,000 in the event of a prepayment. The Agility Loan contains covenants to achieve specified Adjusted EBITDA levels, as defined, limiting capital expenditures, restricting our ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. As of June 30, 2016, we were in compliance with these covenants. The Agility Loan requires a security interest in all of our personal property and intellectual property, second in priority to the Lender and to SaaS Capital Funding II, LLC.

 

In connection with the Agility Loan, Agility Capital is entitled to purchase, under certain circumstances, Shares at the Warrant Price. The initial number of Shares issuable upon exercise of this Warrant is zero (0). On June 30, 2016, if any amounts under the Agility Loan remain outstanding, then the number of Shares issuable upon exercise of this Warrant shall equal $31,250 divided by the Warrant Price. In addition to the foregoing, upon the occurrence of an Event of Default, as defined in the loan agreement, pursuant to Section 5(a) or Section 5(b) of the Agility Loan, the number of Shares that may be acquired thereunder shall increase by an additional number of Shares equal to 5% of the number of Shares issuable thereunder upon the date of such Event of Default, and further increased on the 15th day following such Event of Default and on each Measurement Date by a number of Shares equal to 5% of the number of Shares issuable upon such Measurement Date, until the Event of Default is cured to Agility Capital’s satisfaction or waived in writing by Agility Capital. As of June 30, 2016, as a result of outstanding amounts under the Agility Loan, we issued to Agility Capital a warrant to purchase up to 69,444 shares of our Common Stock at an exercise price of $0.45 per share. This warrant expires on March 11, 2021.

 

We owed $600,000 under the Agility Loan at June 30, 2016.

 

SaaS Capital Loan

 

On May 5, 2016, we entered into the SaaS Capital Loan, with SaaS Capital Funding II, LLC to borrow up to a maximum of $8,000,000. Initial amounts borrowed will accrue interest at the rate of 10.25% per annum with future amounts borrowed bearing interest at the greater of 10.25% or 9.21% plus the three-year treasury rate at the time of advance. Accrued interest on amounts borrowed is payable monthly for the first six months and thereafter 36 equal monthly payments of principal and interest is payable. Prepayments will be subject to a 10%, 6% or 3% of principal premium if prepaid prior to 12 months, between 12 and 24 months, or between 24 months and maturity, respectively. Advances may be requested until May 5, 2018. The initial minimum advance amount of $5,000,000, on May 5, 2016, was used to repay the outstanding Line of Credit balance of $4,572,223. A facility fee of $80,000 was paid by us in connection with the initial advance and an additional $80,000 is payable on May 5, 2017.

 

 
20

 

 

The SaaS Capital Loan contains customary covenants including, but not limited to, covenants to achieve specified Adjusted EBITDA levels and revenue renewal levels, limiting capital expenditures and restricting the our ability to pay dividends, purchase and sell assets outside the ordinary course and incur additional indebtedness. As of June 30, 2016, we were in compliance with such covenants. The occurrence of a material adverse change will be an event of default under the SaaS Capital Loan, in addition to other customary events of default. We granted SaaS Capital Funding II, LLC a security interest in all of our personal property and intellectual property through the SaaS Capital Loan and the Patent, Trademark and Copyright Security Agreement between us and SaaS Capital Funding II, LLC.

 

As of June 30, 2016, in connection with the SaaS Capital Loan, we issued to SaaS Capital Partners II, LP, an affiliate of SaaS Capital Funding II, LLC, a warrant to purchase up to 1,333,333 shares of our common stock at an exercise price of $0.45 per share subject to certain adjustments for dividends, splits or reclassifications. The Warrant is exercisable until the earlier of May 5, 2026, or the date that is 5 years from the date our equity securities are first listed for trading on NASDAQ. We paid approximately $169,000 in financing costs through June 30, 2016.

 

We owed $6,000,000 under the SaaS Capital Loan at June 30, 2016.

 

 

Changes in Cash Flows

 

   

Six-month periods ended

June 30,

 
   

2016

   

2015

 

Cash flows from operating activities:

               

Net loss

  $ (916,506

)

  $ (3,354,142

)

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    549,641       791,926  

Amortization of debt discount and deferred financing cost

    75,798       18,583  

Provision for bad debt

    (4,943

)

    (206,749

)

Fair value of options and warrants

    803,383       1,126,615  

Non-cash expenses paid on company’s behalf

    204,920       -  

Gain on sale of fixed assets

    (447

)

    -  

Changes in operating assets and liabilities:

               

Accounts receivable

    (153,622

)

    (330,277

)

Prepaid expenses and other assets

    (245,521

)

    (196,268

)

Restricted cash

    (500,000

)

    -  

Accounts payable and accrued expenses

    (365,461

)

    446,136  

Deferred revenues

    (7,500

)

    (149,341

)

Other assets

    8,076       (1,576

)

Net cash used in operating activities

    (552,183

)

    (1,855,093

)

                 

Cash flows from investing activities:

               

Capitalized software for internal use

    (1,030,456

)

    (368,041

)

Capital expenditures

    (7,585

)

    (115,473

)

Proceeds from sale of assets

    5,642       -  

Net cash used in investing activities

    (1,032,399

)

    (483,514

)

                 

Cash flows from financing activities:

               

Principal repayments of line of credit

    (87,777

)

    -  

Proceeds from line of credit

    1,803,105       1,600,000  

Payment of financing costs

    (129,678

)

    -  

Net proceeds from exercise of options and warrants

    -       9,586  

Net cash provided by financing activities

    1,585,650       1,609,586  
                 

Effect of exchange rate changes on cash

    (29,497

)

    2,028  
                 

Net (decrease) increase in cash

    (28,429

)

    (726,993

)

 

Comparison of six months ended June 30, 2016 to June 30, 2015

   

The decrease in accounts receivable as of June 30, 2016 when compared to the same period in 2015, is primarily due to improved collection efforts while revenues continued to increase. Accounts payable and accrued expenses decreased during the six-month period ended June 30, 2016 when compared to the same period in 2015 primarily due to lower vendor accruals as well as payments made on existing payables.

 

Cash used in investing activities during the six-month period ended June 30, 2016 consists of capitalization of development costs for internal-use software of approximately $1,030,000. Cash used in investing activities during the six-month period ended June 30, 2015 consisted of recurring purchases of computer equipment and other capital expenditures of approximately $115,000, and capitalization of development costs for internal-use software of approximately $370,000.

 

Cash provided by financing activities during the six-month period ended June 30, 2016 resulted from the proceeds from the $625,000 Agility Loan and $6,000,000 SaaS Capital Loan, offset by the repayments of the Line of Credit of $4,635,000 and the Agility Loan of $25,000 as well as the related financing expenses of approximately $320,000. Cash provided by financing activities during the six-month period ended June 30, 2015 resulted primarily from $1,600,000 in draw downs on the Line of Credit.

 

The increase in net cash flows during the six-month period ended June 30, 2016 was primarily a result of the Agility and SaaS Capital Loans, necessary to support our existing and anticipated growth.

 

 
21

 

 

Exercise of warrants

 

There were no proceeds generated from the exercise of warrants during the six-month period ended June 30, 2016.

  

Other outstanding obligations at June 30, 2016

 

Line of Credit

 

During the three months ended June 30, 2016, we repaid the balance of $4,572,223 owed under the Line of Credit. As of June 30, 2016, we owed $0 under the Line of Credit, $600,000 under the Agility Loan, and $6,000,000 under the SaaS Capital Loan.

 

Warrants

 

As of June 30, 2016, 7,603,716 shares of our Common Stock are issuable pursuant to the exercise of warrants.

 

Options

 

As of June 30, 2016, 13,275,000 shares of our Common Stock are issuable pursuant to the exercise of options.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

We are exposed to a variety of risks, including changes in foreign currency exchange rates and changes in interest rates.

 

Foreign Currency Exchange Risk

 

Transactions that occur in our Subsidiary are exposed to exchange rate fluctuations when converted to our reporting currency. As a result, our earnings are at risk as it relates to exchange rate fluctuations. A relatively small amount of our monetary assets and liabilities are denominated in foreign currencies, principally the British Pound. Fluctuations in these currencies relative to the United States Dollar will result in transaction gains or losses included in net earnings.

 

As of June 30, 2016, we held cash funds of approximately $26,000 in British Pounds in our Subsidiary’s bank. We did not hold any amounts of other foreign currencies. If rates of the British Pound were to strengthen or weaken relative to the United States Dollar, we would realize gains or losses in converting these funds back into United States Dollars. In any event, given the small amounts, we do not expect fluctuations in exchange rates to have a material adverse effect on our business. 

 

Interest Rate Risk

 

A portion of our debt may be exposed to future interest rate fluctuations. As a result, our earnings are at risk in relation to interest rate fluctuations. On May 5, 2016, we entered into the SaaS Capital Loan, allowing us to borrow up to a maximum of $8,000,000 over the next two years with repayment schedules which extend for approximately three further years. While initial amounts borrowed will accrue interest at the rate of 10.25% per annum, future amounts borrowed, if any, will bear interest at the greater of 10.25% or 9.21% plus the three-year treasury rate at the time of advance. Over the past five years, the three-year treasury rate has ranged from approximately 0.29% to approximately 1.38%. While future treasury rates are uncertain, we do not expect fluctuations in our applicable interest rates to have a material adverse effect on our business.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our Chief Executive Officer, who is our principal executive officer, and our Chief Financial Officer, who is our principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended, or the Exchange Act. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of June 30, 2016, our disclosure controls and procedures are effective in ensuring that material information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, including ensuring that such material information is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

 

 
22

 

 

Changes in Internal Control Over Financial Reporting

 

During the quarter ended June 30, 2016, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.  

  

  

  

PART II - OTHER INFORMATION  

 

Item 1. Legal Proceedings

 

From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any legal proceedings, including the following, that we currently believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition or cash flows.

 

McCollum Litigation

 

We are currently involved in a litigation with Jeff McCollum, the former President of our CAKE division, in the Superior Court of the State of California, commenced by us on February 22, 2015, whereby we asserted claims against Mr. McCollum for fraud, breach of contract, and breach of fiduciary duty, among others, following our termination of Mr. McCollum’s employment on September 8, 2014 for cause as a result of, among other things, Mr. McCollum having abandoned his position and professional responsibilities. Mr. McCollum filed a cross complaint alleging breach of contract by us with respect to Mr. McCollum’s employment agreement and commenced a separate action on February 23, 2015 in the Superior Court of the State of California asserting claims against us for violation of California Commercial Code §8401 and breach of fiduciary duty arising from Mr. McCollum’s request to have the restrictive legend removed from his share certificate representing 1.89 million shares of our Common Stock owned by him, and seeking declaratory relief as to whether he is entitled to have the restrictive legend removed from his share certificate. On April 27, 2016, the court granted Mr. McCollum summary adjudication as to his declaratory relief cause of action to have the restrictive legend removed from his share certificate.  

 

  Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

   

On June 9, 2016, we issued a warrant to Santi Pierini, our Chief Operating Officer and President of our CAKE division, to purchase up to 2,000,000 shares of our Common Stock at an exercise price of $0.50 per share. The warrant was issued in consideration of Mr. Pierini’s services to us, and in connection with the cancellation of 2,300,000 previously issued warrants and options by mutual agreement between us and Mr. Pierini. 25% of the shares issuable upon exercise of the warrant vested on June 9, 2016. The warrant vests thereafter in twelve equal quarterly installments commencing on October 1, 2016. The warrant was exempt from registration pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended, or the Securities Act, as not involving any public offering.

 

On June 30, 2016, in connection with an obligation under the Agility Loan when there are amounts outstanding as of June 30, 2016, we issued to Agility Capital a warrant to purchase 69,444 shares of our Common Stock at an exercise price of $0.45 per share. This warrant expires on March 11, 2021. This warrant was exempt from registration pursuant to Section 4(a)(2) under the Securities Act as not involving any public offering.

 

 
23

 

 

Item 6.  Exhibits

 

4.1

Form of Warrant issued on June 9, 2016.*

   

4.2

Form of Warrant issued on June 30, 2016.*

   

10.1

Employment Agreement, dated as of April 12, 2016, between Anthony Mazzarella and Accelerize Inc. (incorporated by reference to the Company’s Current Report on Form 8-K filed on April 13, 2016).

   

10.2

Loan and Security Agreement, dated May 5, 2016, between Accelerize Inc. and SaaS Capital Funding II, LLC (incorporated by reference to the Company’s Current Report on Form 8-K filed on May 6, 2016).

   

10.3

Patent, Trademark and Copyright Security Agreement, dated May 5, 2016, between Accelerize Inc. and SaaS Capital Funding II, LLC (incorporated by reference to the Company’s Current Report on Form 8-K filed on May 6, 2016).

   

10.4

Amendment No. 1 to Employment Agreement, dated as of June 9, 2016, between Brian Ross and Accelerize Inc. (incorporated by reference to the Company’s Current Report on Form 8-K filed on June 13, 2016).

 

 

31.1

Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and15d-14(a).*

 

 

31.2

Certification of Principal Financial Officer Pursuant to Rule 13a-14(a) and 15d-14(a).*

  

  

32.1

Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350.**

 

 

32.2

Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350.**

  

  

101.

The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2016, formatted in XBRL (eXtensible Business Reporting Language): (i) the Balance Sheets, (ii) the Statements of Operations, (iii) the Statements of Comprehensive (Loss) Income, (iv) the Statements of Cash Flows, and (v) related notes to these financial statements.*

 

*

Filed herewith.

**

Furnished herewith.

 

 
24

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  

ACCELERIZE INC.  

  

  

  

  

  

Dated: August 8, 2016

By:  

/s/ Brian Ross                                                               

  

  

  

Brian Ross

President and Chief Executive Officer

(Principal Executive Officer)

  

 

 

 

 

 

 

 

 

Dated: August 8, 2016

By:

/s/ Anthony Mazzarella

 

 

 

Anthony Mazzarella

 

 

 

Chief Financial Officer

 

 

 

(Principal Financial Officer)

 

  

 

25

Exhibit 4.1

 

FORM OF COMMON STOCK PURCHASE WARRANT

 

THIS WARRANT AND THE COMMON STOCK SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THIS WARRANT AND THE COMMON STOCK SHARES ISSUABLE UPON EXERCISE OF THIS WARRANT MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO ACCELERIZE INC. THAT SUCH REGISTRATION IS NOT REQUIRED .

 

 

Right to Purchase up to 2,000,000 shares of Common Stock of Accelerize Inc. (subject to adjustment as provided herein)

 

FORM OF COMMON STOCK PURCHASE WARRANT

No. EW - 03                                   

 Issue Date: June 9, 2016

 

ACCELERIZE INC., a corporation organized and existing under the laws of the State of Delaware (the “Company”), hereby certifies that, for value received, Santi Pierini or its assigns (the “Holder”) is entitled, subject to the terms set forth below and Schedule 1 , to purchase from the Company at any time after the issue date (the “Issue Date”) until 5:00 p.m., E.S.T on the fifth (5th) anniversary of the Issue Date (the “Expiration Date”), up to 2,000,000 fully paid and nonassessable shares of Common Stock at a per share purchase price of $0.50 in accordance with the vesting schedule and termination clauses set forth on Schedule 1. The aforedescribed purchase price per share, as adjusted from time to time as herein provided, is referred to herein as the “Purchase Price.” The number and character of such shares of Common Stock and the Purchase Price are subject to adjustment as provided herein. The Company may reduce the Purchase Price without the consent of the Holder.

 

As used herein the following terms, unless the context otherwise requires, have the following respective meanings:

 

(a)     The term “Company” shall include Accelerize Inc. and any corporation which shall succeed or assume the obligations of Accelerize Inc. hereunder.

 

(b)     The term “Common Stock” includes (a) the Company’s Common Stock, $0.001 par value per share, and (b) any other securities into which or for which any of the securities described in (a) may be converted or exchanged pursuant to a plan of recapitalization, reorganization, merger, sale of assets or otherwise.

 

(c)     The term “Other Securities” refers to any stock (other than Common Stock) and other securities of the Company or any other person (corporate or otherwise) which the holder of the Warrant at any time shall be entitled to receive, or shall have received, on the exercise of the Warrant, in lieu of or in addition to Common Stock, or which at any time shall be issuable or shall have been issued in exchange for or in replacement of Common Stock or Other Securities pursuant to Section 4 herein or otherwise.

 

(d)     The term “Warrant Shares” shall mean the Common Stock issuable upon exercise of this Warrant.

 

 
 

 

 

1.      Exercise of Warrant .

 

1.1.      Number of Shares Issuable upon Exercise . From and after the Issue Date through and including the Expiration Date, the Holder hereof shall be entitled to receive, upon exercise of this Warrant in whole in accordance with the terms of subsection 1.2 or upon exercise of this Warrant in part in accordance with subsection 1.3, up to 2,000 ,000 of shares of Common Stock of the Company, subject to adjustment pursuant to Section 4 and subject to the vesting schedule and termination clauses set forth on Schedule 1.

 

1.2.      Full Exercise . This Warrant may be exercised in full by the Holder hereof by delivery of an original or facsimile copy of the form of subscription attached as hereto Exhibit A (the “Subscription Form”) duly executed by such Holder and surrender of the original Warrant within four (4) days of exercise, to the Company at its principal office or at the office of its Warrant Agent (as provided hereinafter), accompanied by payment, in cash, wire transfer or by certified or official bank check payable to the order of the Company, in the amount obtained by multiplying the number of shares of Common Stock for which this Warrant is then exercisable by the Purchase Price then in effect. This Warrant can also be exercised at Holder’s discretion, in whole or in part, in a “cashless” exercise. In a cashless exercise, the right to purchase each share of Common Stock may be exchanged for that number of shares of Common Stock determined by multiplying the number one (1) by a fraction, the numerator of which will be the difference between (y) the then current Fair Market Value and (z) the exercise price, and the denominator of which will be the then current Fair Market Value.

 

1.3.      Partial Exercise . This Warrant may be exercised in part (but not for a fractional share) by surrender of this Warrant in the manner and at the place provided in subsection 1.2 except that the amount payable by the Holder on such partial exercise shall be the amount obtained by multiplying (a) the number of whole shares of Common Stock designated by the Holder in the Subscription Form by (b) the Purchase Price then in effect. On any such partial exercise, the Company, at its expense, will forthwith issue and deliver to or upon the order of the Holder hereof a new Warrant of like tenor, in the name of the Holder hereof or as such Holder (upon payment by such Holder of any applicable transfer taxes) may request, the whole number of shares of Common Stock for which such Warrant may still be exercised.

 

1.4.      Fair Market Value . Fair Market Value of a share of Common Stock as of a particular date (the “Determination Date”) shall mean:

 

(a)     If the Company’s Common Stock is traded on an exchange or is quoted on the Nasdaq Stock Market, Inc., then the last sale price reported for the last business day immediately preceding the Determination Date;

 

 
 

 

 

(b)     If the Company’s Common Stock is not traded on an exchange or quoted on the Nasdaq Stock Market, Inc. but is traded in the over-the-counter market, then the average of the closing bid and ask prices reported for the last business day immediately preceding the Determination Date;

 

(c)     Except as provided in clause (d) below, if the Company’s Common Stock is not publicly traded, then as the Holder and the Company agree in writing, or in the absence of such agreement, by arbitration in accordance with the rules then standing of the American Arbitration Association, before a single arbitrator to be chosen from a panel of persons qualified by education and training to pass on the matter to be decided; or

 

(d)     If the Determination Date is the date of a liquidation, dissolution or winding up, or any event deemed to be a liquidation, dissolution or winding up pursuant to the Company’s charter, then all amounts to be payable per share to holders of the Common Stock pursuant to the charter in the event of such liquidation, dissolution or winding up, plus all other amounts to be payable per share in respect of the Common Stock in liquidation under the charter, assuming for the purposes of this clause (d) that all of the shares of Common Stock then issuable upon exercise of all of the Warrants are outstanding at the Determination Date.

 

1.5.      Company Acknowledgment . The Company will, at the time of the exercise of the Warrant, upon the request of the Holder hereof acknowledge in writing its continuing obligation to afford to such Holder any rights to which such Holder shall continue to be entitled after such exercise in accordance with the provisions of this Warrant. If the Holder shall fail to make any such request, such failure shall not affect the continuing obligation of the Company to afford to such Holder any such rights.

 

1.6.      Delivery of Stock Certificates, etc. on Exercise . The Company agrees that the shares of Common Stock purchased upon exercise of this Warrant shall be deemed to be issued to the Holder hereof as the record owner of such shares as of the close of business on the date on which this Warrant shall have been surrendered and payment made for such shares as aforesaid. As soon as practicable after the exercise of this Warrant in full or in part, and in any event within three (3) business days thereafter, the Company at its expense (including the payment by it of any applicable issue taxes) will cause to be issued in the name of and delivered to the Holder hereof, or as such Holder (upon payment by such Holder of any applicable transfer taxes) may direct in compliance with applicable securities laws, a certificate or certificates for the number of duly and validly issued, fully paid and nonassessable shares of Common Stock (or Other Securities) to which such Holder shall be entitled on such exercise, plus, in lieu of any fractional share to which such Holder would otherwise be entitled, cash equal to such fraction multiplied by the then Fair Market Value of one full share of Common Stock, together with any other stock or other securities and property (including cash, where applicable) to which such Holder is entitled upon such exercise pursuant to Section 1 or otherwise.

 

2.      Adjustments.

 

2.1.      Reorganization, Consolidation, Merger, etc . In case at any time or from time to time, the Company shall (a) effect a reorganization, (b) consolidate with or merge into any other person or (c) transfer all or substantially all of its properties or assets to any other person under any plan or arrangement contemplating the dissolution of the Company, then, in each such case, as a condition to the consummation of such a transaction, proper and adequate provision shall be made by the Company whereby the Holder of this Warrant, on the exercise hereof as provided in Section 1, at any time after the consummation of such reorganization, consolidation or merger or the effective date of such dissolution, as the case may be, shall receive, in lieu of the Common Stock (or Other Securities) issuable on such exercise prior to such consummation or such effective date, the stock and other securities and property (including cash) to which such Holder would have been entitled upon such consummation or in connection with such dissolution, as the case may be, if such Holder had so exercised this Warrant, immediately prior thereto, all subject to further adjustment thereafter as provided in Section 3.

 

 
 

 

 

This Warrant shall fully vest and become exercisable immediately prior to the effective date of a Change in Control. For purposes of this Warrant, the term “Change in Control” shall mean (i) the sale of all or substantially all of the assets of the Company, (ii) the sale of more than fifty percent of the outstanding capital stock of the Company in a non-public sale, (iii) the dissolution or liquidation of the Company or (iv) any merger, share exchange, consolidation or other reorganization or business combination of the Company if immediately after such transaction either (A) persons who were directors of the Company immediately prior to such transaction do not constitute at least a majority of the directors of the surviving entity or (B) persons who hold a majority of the voting capital stock of the surviving entity are not persons who held a majority of the voting capital stock of the Company immediately prior to the transaction; provided, however, that the term “Change in Control” shall not include a public offering of capital stock of the Company that is effected pursuant to a registration statement filed with, and declared effective by, the Securities and Exchange Commission under the Securities Act of 1933, as amended.

 

 

2.2.      Dissolution . In the event of any dissolution of the Company following the transfer of all or substantially all of its properties or assets, the Company, prior to such dissolution, shall at its expense deliver or cause to be delivered the stock and other securities and property (including cash, where applicable) receivable in accordance with Section 2.1 by the Holder of the Warrants upon their exercise after the effective date of such dissolution pursuant to this Section 2.

 

2.3.      Continuation of Terms . Upon any reorganization, consolidation, merger or transfer (and any dissolution following any transfer) referred to in this Section 2, this Warrant shall continue in full force and effect and the terms hereof shall be applicable to the Other Securities and property receivable on the exercise of this Warrant after the consummation of such reorganization, consolidation or merger or the effective date of dissolution following any such transfer, as the case may be, and shall be binding upon the issuer of any Other Securities, including, in the case of any such transfer, the person acquiring all or substantially all of the properties or assets of the Company, whether or not such person shall have expressly assumed the terms of this Warrant as provided in Section 3.

 

3.      Extraordinary Events Regarding Common Stock . In the event that the Company shall (a) issue additional shares of Common Stock as a dividend or other distribution on outstanding Common Stock, (b) subdivide its outstanding shares of Common Stock, or (c) combine its outstanding shares of the Common Stock into a smaller number of shares of the Common Stock, then, in each such event, the Purchase Price shall, simultaneously with the happening of such event, be adjusted by multiplying the then Purchase Price by a fraction, the numerator of which shall be the number of shares of Common Stock outstanding immediately prior to such event and the denominator of which shall be the number of shares of Common Stock outstanding immediately after such event, and the product so obtained shall thereafter be the Purchase Price then in effect. The Purchase Price, as so adjusted, shall be readjusted in the same manner upon the happening of any successive event or events described herein in this Section 3. The number of shares of Common Stock that the Holder of this Warrant shall thereafter, on the exercise hereof as provided in Section 1, be entitled to receive shall be adjusted to a number determined by multiplying the number of shares of Common Stock that would otherwise (but for the provisions of this Section 3) be issuable on such exercise by a fraction of which (a) the numerator is the Purchase Price that would otherwise (but for the provisions of this Section 3) be in effect, and (b) the denominator is the Purchase Price in effect on the date of such exercise.

 

 
 

 

 

4.      Certificate as to Adjustments . In each case of any adjustment or readjustment in the shares of Common Stock (or Other Securities) issuable on the exercise of the Warrants, the Company at its expense will promptly cause its Chief Financial Officer or other appropriate designee to compute such adjustment or readjustment in accordance with the terms of the Warrant and prepare a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based, including a statement of (a) the consideration received or receivable by the Company for any additional shares of Common Stock (or Other Securities) issued or sold or deemed to have been issued or sold, (b) the number of shares of Common Stock (or Other Securities) outstanding or deemed to be outstanding, and (c) the Purchase Price and the number of shares of Common Stock to be received upon exercise of this Warrant, in effect immediately prior to such adjustment or readjustment and as adjusted or readjusted as provided in this Warrant. The Company will forthwith mail a copy of each such certificate to the Holder of the Warrant and any Warrant Agent of the Company (appointed pursuant to Section 9 hereof).

 

5.      Reservation of Stock, etc. Issuable on Exercise of Warrant; Financial Statements . The Company will at all times reserve and keep available, solely for issuance and delivery on the exercise of the Warrants, all shares of Common Stock (or Other Securities) from time to time issuable on the exercise of the Warrant.

 

6.      Replacement of Warrant . On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of any such loss, theft or destruction of this Warrant, on delivery of an indemnity agreement or security reasonably satisfactory in form and amount to the Company or, in the case of any such mutilation, on surrender and cancellation of this Warrant, the Company at its expense, twice only, will execute and deliver, in lieu thereof, a new Warrant of like tenor.

 

7.      Warrant Agent . The Company may, by written notice to the Holder of the Warrant, appoint an agent (a “Warrant Agent”) for the purpose of issuing Common Stock (or Other Securities) on the exercise of this Warrant pursuant to Section 1, and replacing this Warrant pursuant to Section 6, or any of the foregoing, and thereafter any such issuance or replacement, as the case may be, shall be made at such office by such Warrant Agent.

 

 
 

 

 

8.      Transfer on the Company’s Books . Until this Warrant is transferred on the books of the Company, the Company may treat the registered holder hereof as the absolute owner hereof for all purposes, notwithstanding any notice to the contrary.

 

9.      Notices . All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received), or the first business day following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur or (c) three business days after deposited in the mail if delivered pursuant to subsection (ii) above . The addresses for such communications shall be: (i) if to the Company to: 20411 SW Birch St. Ste. 250, Newport Beach, CA 92660, and (ii) if to the Holder, to the address in the Company books. The Company may change its address for notices but only to an address and fax number located in the United States.

 

10.      Miscellaneous . This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought. This Warrant shall be construed and enforced in accordance with and governed by the laws of New York. Any dispute relating to this Warrant shall be adjudicated in New York County in the State of New York. The headings in this Warrant are for purposes of reference only, and shall not limit or otherwise affect any of the terms hereof. The invalidity or unenforceability of any provision hereof shall in no way affect the validity or enforceability of any other provision.

 

IN WITNESS WHEREOF, the Company has executed this Warrant as of the date first written above.

 

 

ACCELERIZE INC.

 

 

 

 

 

By:                                                                         

 

Name:                                                                     

 

Title:                                                                           

Witness:

 

 
 

 

 

Schedule 1 to Warrant Agreement

 

Name of Holder: Santi Pierini

 

Date of Grant of Warrant: June 9, 2016

 

Number of shares of Common Stock: up to 2,000,000

 

Exercise Price (per share): $0.50

 

Vesting: Quarterly over 3 years:                                                                 

 

June 9, 2016               25.00%

October 1, 2016          31.25%

January 1, 2017          37.50%

April 1, 2017               43.75%

July 1, 2017               50.00%

October 1, 2017          56.25%

January 1, 2018          62.50%

April 1, 2018               68.75%

July 1, 2018               75.00%  

October 1, 2018          81.25%

January 1, 2019          87.50%

April 1, 2019               93.75%

July 1, 2019               100.00%

 

Provided, that vesting shall immediately cease upon the date of Holder’s termination of employment (ex. Employee quits or is terminated by Company) with the Company and Holder shall thereafter only be entitled to acquire shares that have vested prior to such date and such right shall expire three months from the date of termination of employment (ex. Employee quits or is terminated by Company) . However, if Holder is terminated by Company for “cause”, as defined in Holder’s Employment Agreement, all vested and unvested warrants will immediately be forfeited by Holder.

 

 
 

 

 

Exhibit A

FORM OF SUBSCRIPTION

(to be signed only on exercise of Warrant)

TO:     ACCELERIZE INC.

 

The undersigned, pursuant to the provisions set forth in the attached Warrant (No.____), hereby irrevocably elects to purchase (check applicable box):

 

___     ________ shares of the Common Stock covered by such Warrant; or

 

The undersigned herewith makes payment of the full purchase price for such shares at the price per share provided for in such Warrant, which is $___________. Such payment takes the form of (check applicable box or boxes):

 

___     $__________ in lawful money of the United States; and/or

 

The undersigned requests that the certificates for such shares be issued in the name of, and delivered to                                                                         whose address is__________________________________________________________________________

 

The undersigned represents and warrants that all offers and sales by the undersigned of the securities issuable upon exercise of the within Warrant shall be made pursuant to registration of the Common Stock under the Securities Act, or pursuant to an exemption from registration under the Securities Act.

 

Dated:                               

 

 

 

 

(Signature must conform to name of holder

as specified on the fact of the Warrant.)

 

 

   
   
  (Address)

 

 

 

Exhibit 4.2

 

THIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH APPLICABLE LAW.

 

WARRANT TO PURCHASE COMMON STOCK

 

 

Corporation:      ACCELERIZE INC.

Number of Shares:

See below

Class of Securities: Common Stock
Initial Exercise Price: [the closing price on the day prior to the issue date]
Issue Date: March 11, 2016
Expiration Date:  March 11, 2021

     

This Warrant Certifies That , for good and valuable consideration, AGILITY CAPITAL II, LLC or its registered assignee (“Holder”) is entitled to purchase the number of fully paid and nonassessable shares of the class of securities (the “Shares”) of Accelerize Inc., a Delaware corporation (the “Company”) at the initial exercise price per Share (the “Warrant Price”) set forth above and herein, and as adjusted pursuant to Article 2 of this Warrant.

 

This Warrant is being issued to Holder in connection with that certain Loan Agreement by and between Agility Capital II, LLC (“Lender”) and Company dated as of even date herewith (the “Loan Agreement”). The initial number of Shares issuable upon exercise of this Warrant is zero (0). On June 30, 2016, if any amounts under the Loan Agreement remain outstanding, then the number of Shares issuable upon exercise of this Warrant shall equal $31,250 divided by the Warrant Price (the “Initial Shares”). In addition to the foregoing, upon the occurrence of an Event of Default (as defined in the Loan Agreement) pursuant to Section 5(a) or Section 5(b) of the Loan Agreement, the number of Shares that may be acquired hereunder shall increase by an additional number of Shares equal to 5% of the number of Shares issuable hereunder upon the date of such Event of Default, and further increased on the 15 th day following such Event of Default and on each 15 th day thereafter (each, a “Measurement Date”) by a number of Shares equal to 5% of the number of Shares issuable upon such Measurement Date, until the Event of Default is cured to Lender’s satisfaction or waived in writing by Lender.

 

1.

Exercise

 

1.1      Method of Exercise . Holder may exercise this Warrant by delivering this Warrant and a duly executed Notice of Exercise in substantially the form attached as Appendix 1 to the principal office of the Company. Unless Holder is exercising the conversion right set forth in Section 1.2, Holder shall also deliver to the Company a check for the aggregate Warrant Price for the Shares being purchased.

 

1.2     Conversion Right . In lieu of exercising this Warrant as specified in Section 1.1, Holder may from time to time convert this Warrant, in whole or in part, into a number of Shares determined by dividing (a) the aggregate fair market value of the Shares or other securities otherwise issuable upon exercise of this Warrant minus the aggregate Warrant Price of such Shares by (b) the fair market value of one Share. The fair market value of the Shares shall be determined pursuant to Section 1.3.

 

1.3     Fair Market Value . If the Shares are traded regularly in a public market, the fair market value of the Shares shall be the closing price of the Shares reported for the business day immediately before Holder delivers its Notice of Exercise to the Company. Otherwise, the value shall be as reasonably determined by the Board of Director of the Company in good faith.

 

1.4     Delivery of Certificate and New Warrant . Promptly after Holder exercises or converts this Warrant, the Company shall deliver to Holder certificates for the Shares acquired and, if this Warrant has not been fully exercised or converted and has not expired, a new warrant representing the Shares not so acquired.

 

1.5     Replacement of Warrants . On receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant and, in the case of loss, theft or destruction, on delivery of an indemnity agreement reasonably satisfactory in form and amount to the Company or, in the case of mutilation, or surrender and cancellation of this Warrant, the Company at its expense shall execute and deliver, in lieu of this Warrant, a new warrant of like tenor.

 

 
1.

 

 

2.

Adjustments To The Shares .

 

2.1     Dividends . If the Company declares or pays a dividend on its Common Stock or other securities, then upon exercise of this Warrant, for each Share acquired, Holder shall receive, without cost to Holder, the property to which Holder would have been entitled had Holder owned the Shares of record as of the date the dividend occurred.

 

2.2     Reclassification, Exchange or Substitution . Upon any reclassification, exchange, substitution, or other event that results in a change of the number and/or class of the securities issuable upon exercise or conversion of this Warrant, Holder shall be entitled to receive, upon exercise or conversion of this Warrant, the number and kind of securities and property that Holder would have received for the Shares if this Warrant had been exercised immediately before such reclassification, exchange, substitution, or other event. The Company or its successor shall promptly issue to Holder a new Warrant for such new securities or other property. The new Warrant shall provide for adjustments which shall be as nearly equivalent as may be practicable to the adjustments provided for in this Article 2 including, without limitation, adjustments to the Warrant Price. The provisions of this Section 2.2 shall similarly apply to successive reclassifications, exchanges, substitutions, or other events. Upon the closing of any Acquisition the successor entity shall assume the obligations of this Warrant, and then this Warrant shall be exercisable for the same securities, cash, and property as would be payable for the Shares issuable upon exercise of the unexercised portion of this Warrant as if such Shares were outstanding on the record date for the Acquisition. For the purpose of this Warrant, “Acquisition” means any sale, license, or other disposition of all or substantially all of the assets (including intellectual property) of the Company, or any reorganization, consolidation, or merger of the Company where the holders of the Company’s securities before the transaction beneficially own less than 50% of the outstanding voting securities of the surviving entity after the transaction.

 

2.3      Adjustments for Combinations, Etc . If at any time while this Warrant, or any portion thereof, remains outstanding and unexpired, the outstanding Shares are reverse-split, combined or consolidated, by reclassification or otherwise, into a lesser number of shares, the Warrant Price shall be proportionately increased and the number of Shares issuable upon exercise or conversion of this Warrant shall be proportionately decreased. If the outstanding Shares are split, combined or consolidated, by reclassification or otherwise, into a greater number of shares, the Warrant Price shall be proportionately decreased and the number of Shares issuable upon exercise of or conversion of this Warrant shall be proportionately increased.

 

2.4      No Impairment . The Company shall not, by amendment of its Certificate of Incorporation or through a reorganization, transfer of assets, consolidation, merger, dissolution, issue, or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed under this Warrant by the Company, but shall at all times in good faith assist in carrying out all the provisions of this Article 2 and in taking all such action as may be necessary or appropriate to protect Holder’s rights under this Article against impairment. If the Company takes any action affecting the Shares other than as described above that adversely affects Holder’s rights under this Warrant, the Warrant Price shall be adjusted downward and the number of Shares issuable upon exercise of this Warrant shall be adjusted upward in such a manner that the aggregate Warrant Price of this Warrant is unchanged.

 

2.5     Certificate as to Adjustments . Upon each adjustment of the Warrant Price or the Shares, the Company at its expense shall promptly compute such adjustment, and furnish Holder with a certificate of its Chief Financial Officer or other authorized officer setting forth such adjustment and the facts upon which such adjustment is base and the Warrant Price in effect upon the date thereof and the type and number of Shares issuable under the Warrant on the date hereof.

 

 
2.

 

 

3.

Representations And Covenants Of The Company .

 

3.1      Representations and Warranties . The Company represents and warrants to the Holder that all Shares that may be issued upon the exercise of the purchase right represented by this Warrant, and all securities, if any, issuable upon conversion of the Shares, shall, upon issuance, be duly authorized, validly issued, fully paid and nonassessable, and free of any liens and encumbrances.

 

3.2     Notice of Certain Events . If the Company proposes at any time (a) to declare any dividend or distribution upon its common stock, whether in cash, property, stock, or other securities and whether or not a regular cash dividend; (b) to offer for subscription pro rata to the holders of any class or series of its stock any additional shares of stock of any class or series or other rights; (c) to effect any reclassification or recapitalization of common stock; (d) effectuate an Acquisition or otherwise merge or consolidate with or into any other corporation, or sell, lease, license, or convey all or substantially all of its assets, or to liquidate, dissolve or wind up (each, a “Liquidation Event”); or (e) offer holders of registration rights the opportunity to participate in an underwritten public offering of the company’s securities for cash, then, in connection with each such event, the Company shall give Holder (1) at least 10 days prior written notice of the date on which a record will be taken for such dividend, distribution, or subscription rights (and specifying the date on which the holders of common stock will be entitled thereto) or for determining rights to vote, if any, in respect of the matters referred to in (a) and (b) above; (2) in the case of the matters referred to in (c) and (d) above at least 10 days prior written notice of the date when the same will take place (and specifying the date on which the holders of common stock will be entitled to exchange their common stock for securities or other property deliverable upon the occurrence of such event); and (3) in the case of the matter referred to in (e) above, the same notice as is given to the holders of such registration rights.

 

3.3      Lock Up . Holder hereby agrees that it shall not sell, transfer, make any short sale of, any Shares held by Holder until the earlier to occur of (i) the six month anniversary of the Issue Date, (ii) the date the loan(s) owing to Senior Lender (as defined in the Loan Agreement) are repaid, or (iii) the occurrence of a Liquidation Event.

 

3.4     Information Rights . So long as the Holder holds this Warrant and/or any of the Shares, the Company shall deliver to the Holder (a) promptly after mailing, copies of all communiqués to the shareholders of the Company, (b) promptly after delivery to any commercial bank or other financial institution that provides working capital financing to the Company, quarterly and annual financial statements of the Company (or if the Company does not have a commercial bank or other financial institution that provides it working capital, then within one hundred twenty (120) days after the end of each fiscal year of the Company, the annual financial statements of the Company).

 

4.

Miscellaneous.

 

4.1     Term . This Warrant is exercisable, in whole or in part, at any time and from time to time on or before the Expiration Date set forth above.

 

4.2     Legends . This Warrant and the Shares (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) shall be imprinted with a legend in substantially the following form:

 

THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT IN ACCORDANCE WITH APPLICABLE LAW.

 

4.3     Compliance with Securities Laws on Transfer . This Warrant and the Shares issuable upon exercise this Warrant (and the securities issuable, directly or indirectly, upon conversion of the Shares, if any) may not be transferred or assigned in whole or in part without compliance with applicable federal and state securities laws by the transferor and the transferee.

 

4.4     Transfer Procedure . Subject to the provisions of Section 4.3, Holder may transfer all or part of this Warrant or the Shares issuable upon exercise of this Warrant (or the securities issuable, directly or indirectly, upon conversion of the Shares, if any) by giving the Company written notice of the portion of the Warrant being transferred setting forth the name, address and taxpayer identification number of the transferee and surrendering this Warrant to the Company for reissuance to the transferee(s) (and Holder, if applicable), provided that no such notice shall be required for a transfer to an affiliate of Holder.

 

 
3.

 

 

4.5     Waiver . This Warrant and any term hereof may be changed, waived, discharged or terminated only by an instrument in writing signed by the party against which enforcement of such change, waiver, discharge or termination is sought.

 

4.6     Attorneys’ Fees . In the event of any dispute between the parties concerning the terms and provisions of this Warrant, the party prevailing in such dispute shall be entitled to collect from the other party all costs incurred in such dispute, including reasonable attorneys’ fees.

 

[signature page follows]

 

 
4.

 

 

4.7     Governing Law . This Warrant shall be governed by and construed in accordance with the laws of the State of California, without giving effect to its principles regarding conflicts of law.

 

 

ACCELERIZE INC.

   
   
 

By:                                                                

   
 

Name:                                                            

   
 

Title:                                                              

 

 
5.

 

 

APPENDIX 1

 

NOTICE OF E X ERCISE

 

1.     The undersigned hereby elects to purchase ______________ shares of the Common Stock of Accelerize Inc. pursuant to the terms of the attached Warrant, and tenders herewith payment of the purchase price of such shares in full.

 

1.     The undersigned hereby elects to convert the attached Warrant into Shares in the manner specified in Section 1.2 of the Warrant. This conversion is exercised with respect to ______________ of the Shares covered by the Warrant.

 

[Strike paragraph that does not apply.]

 

2.     Please issue a certificate or certificates representing said shares in the name of the undersigned or in such other name as is specified below:

 

Agility Capital II, LLC

Or Registered Assignee

 

3.     The undersigned represents it is acquiring the shares solely for its own account and not as a nominee for any other party and not with a view toward the resale or distribution thereof except in compliance with applicable securities laws.

 

Agility Capital II, LLC or Registered Assignee

   
     
     
                                                                                               

(Signature)

   
     
     
                                                                                               

(Date)

   

 

 

Exhibit 31.1

 

CERTIFICATION

Pursuant to Rule 13a-14(a) and 15d-14(a)

Under the Securities Exchange Act of 1934, as Amended

 

I, Brian Ross, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2016 of Accelerize Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: August 8, 2016

 

/s/ Brian Ross

Brian Ross

President and Chief Executive Officer

(Principal Executive Officer)

 

 

Exhibit 31.2

 

CERTIFICATION

Pursuant to Rule 13a-14(a) and 15d-14(a)

Under the Securities Exchange Act of 1934, as Amended

 

I, Anthony Mazzarella, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended June 30, 2016 of Accelerize Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the period presented in this report;

 

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal controls over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: August 8, 2016

 

/s/ Anthony Mazzarella

Anthony Mazzarella

Chief Financial Officer

(Principal Financial Officer)

 

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report (the “Report”) of Accelerize Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof, I, Brian Ross, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: August 8, 2016

By: /s/ Brian Ross

  

Brian Ross

President and Chief Executive Officer

(Principal Executive Officer)

 

 

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report (the “Report”) of Accelerize Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2016 as filed with the Securities and Exchange Commission on the date hereof, I, Anthony Mazzarella, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

 

1.

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: August 8, 2016

By: /s/ Anthony Mazzarella

  

Anthony Mazzarella

Chief Financial Officer

(Principal Financial Officer)